-
Foxo4 PeptideCAS No.: 2460055-10-9
Appearance: White crystalline powder
MF: C228H388N86O64
MW: 5358
Specifications: Raw powder or vials form
Purity: NLT 99.12%
Solubility:... -
Tirzepatide for Weight LossCAS No.: 2023788-19-2
Appearance: White powder
MF: C225H348N48O68
MW: 4813
Specifications: Raw powder or vials form
Purity: NLT 99.985%
Solubility: Easily... -
Thymosin Alpha 1 PeptideCAS No.: 62304-98-7
Appearance: White powder
MF: C129H215N33O55
MW: 3108.28
Specifications: Raw powder or vials form
Purity: NLT 99.62%
Solubility: Easily... -
Tesamorelin PowderCAS No: 218949-48-5
Synonyms: Tesamorelin acetate; GHRH (1-44) analog; TH9507
Appearance: White to off-white powder
MF/MW: C221H366N72O67S; 5135.86
Sequence:... -
Survodutide PeptideCAS No.: 2805997-46-8
Appearance: White powder
MF: C192H289N47O61
MW: 4231.69
Specifications: Raw powder or vials form
Purity: NLT 99.78%
Solubility: Easily... -
Sermorelin PowderCAS No: 86168-78-7
Synonyms: Sermorelin acetate; GHRH(1-29)-NH₂; GRF(1-29)
Appearance: White to off-white powder
MF/MW: C149H246N44O42S; 3357.93
Sequence:... -
Semax PeptideCAS No.: 80714-61-0
Appearance: White to off-white powder
MF: C37H51N9O10S
MW: 813.92
Specifications: Raw powder or vials form
Purity: NLT 99.51%
Solubility:... -
Pt 141 Peptide PowderCAS No.: 189691-06-3
Appearance: White powder
MF: C50H68N14O10
MW: 1025.18
Specifications: Raw powder or vials form
Purity: NLT 99.85%
Solubility: Easily... -
Mots‑C PeptideCAS No.: 1627580-64-6
Appearance: White powder
MF: C101H152N28O22S2
MW: 2174.62
Specifications: Raw powder or vials form
Purity: NLT 99.78%
Solubility: Easily... -
Ghrp PeptideCAS No: 158861-67-7
Synonyms:GHRP-2; Growth Hormone Releasing Peptide-2; Pralmorelin
Appearance: White to off-white powder
MF/MW: C45H55N9O6; 817.97
Sequence:... -
Dsip Peptide PowderCAS No.: 62568-57-4
Appearance: White powder
MF: C35H48N10O15
MW: 848.82
Specifications: Raw powder or vials form
Purity: NLT 99.68%
Solubility: Soluble in... -
ARA 290 PowderCAS No.: 1208243-50-8
Appearance: White powder
MF: C51H84N16O21
MW: 1257.31
Specifications: Raw powder or vials form
Purity: NLT 99.72%
Solubility: Soluble in...
WebApr 19, 2023 · FOXO4-D-Retro-Inverso (FOXO4-DRI), a synthesis peptide as a specific FOXO4 blocker, selectively induced dissociation of the FOXO4-p53 complex and nuclear exclusion of p53....
WebMar 5, 2018 · This lengthy post covers the topic of setting up and running a self-experiment, a human trial of a single individual, to assess the senolytic effects of the peptide FOXO4...
WebMar 23, 2017 · In this issue of Cell, Baar et al. show how FOXO4 protects senescent cell viability by keeping p53 sequestered in nuclear bodies, preventing it from inducing apoptosis. Disrupting...
WebNov 10, 2020 · The four FOXO proteins in humans — FOXO1, FOXO3, FOXO4 and FOXO6 — belong to a large family of forkhead box (Fox) transcription factors that share a highly...
WebUnder conditions where it was well tolerated in vivo, this FOXO4 peptide neutralized doxorubicin-induced chemotoxicity. Moreover, it restored fitness, fur density, and renal function in both fast...
WebOct 21, 2021 · Recently, it was shown that by targeting TP53 and disrupting the FOXO4-TP53 interaction with a novel peptide, FOXO4-DRI, senescent cells underwent TP53...

